Fer-1 treatment improved the impaired insulin sensitivity, disrupted estrous cycle, increased LH/FSH ratio, hyperandrogenism, and abnormal ovarian morphologies in PCOS rats. The gene discussed is PLOD1; the disease is hyperandrogenism.